Document is current
Any future updates will be listed below
-
Authors
Scirgolea, Caterina
Sottile, Rosa http://orcid.org/0000-0003-2950-9508
De Luca, Marco http://orcid.org/0000-0001-8310-5526
Susana, Alberto
Carnevale, Silvia
Puccio, Simone http://orcid.org/0000-0003-4007-4365
Ferrari, Valentina
Lise, Veronica http://orcid.org/0000-0001-7978-4837
Contarini, Giorgia
Scarpa, Alice
Scamardella, Eloise
Feno, Simona
Camisaschi, Chiara
De Simone, Gabriele
Basso, Gianluca
Giuliano, Desiree http://orcid.org/0000-0003-0576-4125
Mazza, Emilia Maria Cristina http://orcid.org/0000-0003-2424-3640
Gattinoni, Luca http://orcid.org/0000-0003-2239-3282
Roychoudhuri, Rahul
Voulaz, Emanuele
Di Mitri, Diletta
Simonelli, Matteo
Losurdo, Agnese
Pozzi, Davide
Tsui, Carlson http://orcid.org/0000-0003-0642-814X
Kallies, Axel http://orcid.org/0000-0002-6312-6968
Timo, Sara
Martano, Giuseppe http://orcid.org/0000-0002-5963-4580
Barberis, Elettra
Manfredi, Marcello
Rescigno, Maria http://orcid.org/0000-0002-6464-509X
Jaillon, Sebastien
Lugli, Enrico http://orcid.org/0000-0002-1964-7678
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (AIRC IG 2017 – ID 20676, AIRC IG 2022 – ID 27391, AIRC 5×1000 program UniCanVax 22757, AIRC/FIRC fellowship, AIRC/FIRC fellowship)
Cancer Research Institute (CRI Lloyd J. Old STAR (CRI award 3914))
- License Information
-
More Information
Article History
Received: 20 October 2023
Accepted: 10 July 2024
First Online: 28 August 2024
Competing interests
: C.S and E.L. submitted a patent on the use of NaCl to improve adoptive T cell therapy (PCT/EP2023/063475). E.L. received research grants from Bristol Myers Squibb on a topic unrelated to this paper, royalties from the National Institutes of Health for a patent on methods to develop T memory stem cells and consulting fees from BD Biosciences, Biolegend and Swarm Therapeutics. The other authors declare no competing interests.
